Clinical Trial Update: The Management of Resistant Hypertension in Kidney Transplant Patients Using Chlorthalidone [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating chlorthalidone for resistant hypertension in kidney transplant patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Resistant Hypertension

Drugs mentioned

• Chlorthalidone (chlorthalidone)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Resistant Hypertension in Kidney Transplant Patients | Phase 4 | Status: WITHDRAWN